GY Medical Inspection Company Research On Risk Evaluation And Control Of Accounts Receivable Securitization

The medical industry is closely related to the health problems of every family.The stable and healthy development of the medical industry is one of the basic conditions for the stable society to speed up the national economic development.In recent years,the state has made great efforts to optimize the ecological environment of the pharmaceutical industry.From the implementation of reform policies such as "two-ticket system" and "centralized procurement",we can see the importance of the healthy development of the pharmaceutical industry.Medical devices started late in our country,medical devices have been mainly imported.In recent years,the development speed of medical devices industry is obviously accelerating.The country is also vigorously advocating domestic substitution,the market size is increasing,and enterprises are achieving scale,but it also generates many different problems,including the pain point of the pharmaceutical circulation industry.The main performance is the high proportion of credit sales,slow turnover rate of receivables and so on.In the scale of the market at the same time,credit sales are also growing.The accounts receivable of most pharmaceutical distribution enterprises account for more than half of their total assets.Combined with the characteristics of the industry,the financing method of accounts receivable asset securitization can be used to solve the large amount of deposited accounts receivable,activate the liquidity of assets to obtain future funds in advance,and greatly improve the cost and efficiency of capital use of enterprises.Based on the summary of relevant literature on asset securitization and accounts receivable asset securitization,this paper adopted literature research method,case study method and comparative analysis method,combined with relevant concepts and theoretical basis of accounts receivable asset securitization,and made in-depth research and discussion on the cases of the implementation process of accounts receivable asset securitization business of GY Medical testing Company.This paper evaluates the problems,impacts and risks generated in the process of its implementation,extracting valuable thought-provoking problems,and tries to put forward effective solutions and management methods,hoping to provide reference for many similar medical device companies,and open another window for medical device circulation enterprises due to financing difficulties and high debt.Have an alternative plan and approach.As a state-owned enterprise in the field of medical device circulation,GY medical testing Company not only has the industry in common,but also has the uniqueness of stateowned enterprise management.Its parent company is one of the first listed enterprises of receivables assets securitization of medical device enterprises in China,and GY medical testing Company,as its subsidiary,also participated in this financing plan.This example summarizes the risks in the process of managing and controlling accounts receivable asset securitization of GY medical testing Company through the whole implementation process of accounts receivable securitization,and proposes corresponding solutions,which can provide reference and reference for other medical device peers in the future implementation of accounts receivable securitization.It is helpful to optimize and develop asset securitization projects such as accounts receivable in the capital market,guide investors to gradually transfer savings assets to investment,and promote the growth and development of the capital market.